In fact, AhR expression is markedly downregulated in the inflamed tissue of CD patients [124], and, in agreement to what observed in mice, treatment of human IBD mucosal cells with Ficz resulted in decreased IFN-γ expression and upregulation of IL-22. The gene discussed is IL22; the disease is inflammatory bowel disease.